Search Results 1011-1020 of 18074 for monoclonal antibody

  1. A Study Of The Safety And Drug/Body Interactions Of BGB-3111 For Patients With B-Cell Lymphoid Malignancies - Mayo Clinic

    Monoclonal antibody within 4 weeks. Not recovered from toxicity of any prior chemotherapy to grade ≤ 1. History of other active malignancies within 2 years ...

  2. Safety Study Of SEA-CD40 In Cancer Patients - Mayo Clinic

    Other monoclonal antibodies, antibody-drug conjugates, or radioimmunoconjugates: 4 weeks (2 weeks with documented disease progression);; T-cell or other cell ...

  3. Mike M. Bierle, M.D. - Doctors and Medical Staff - Mayo Clinic

    Professional memberships. 2021 - present. Leadership CommitteeCOVID-19 Monoclonal Antibody Treatment (MATRx) Team. 2021 - present. Committee Member ...

  4. Headaches and hormones: What's the connection? - Mayo Clinic

    Your healthcare professional also might recommend monthly injections of a calcitonin gene-related peptide monoclonal antibody. The injections may help ...

  5. Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis - Mayo Clinic

    Clinical Trials · Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis · More about research at ...

  6. Poor antibody response for COVID vaccine in patients with cancer - Mayo Clinic

    Patients with cancer showed impaired humoral response. Immunocompetent patients had significantly higher antibody levels than the other patients. A greater ...

  7. A Study Of Glofitamab And Lenalidomide In People With Mantle Cell Lymphoma - Mayo Clinic

    -History of severe allergic or anaphylactic reactions to monoclonal antibody therapy (or recombinant antibody-related fusion proteins) -Patient with history ...

  8. Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as rituximab may block tumor growth in different ways by targeting certain cells. LMP-specific T-cells are special immune system ...

  9. CAR-T Cell Therapy Clinical Trials - Mayo Clinic Research

    ... monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in ...

  10. A Study Of MPDL3280A (Anti-PD-L1 Antibody) Combined With Carboplatin And Paclitaxel , And With Or Without Bevacizumab, For Patients Who Have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

    A Study Of MPDL3280A (Anti-PD-L1 Antibody) Combined With Carboplatin And Paclitaxel , And With Or Without Bevacizumab, For Patients Who Have Stage IV Non- ...